Article Tag: Monsanto

Groundwork BioAg has announced that Andrew Duff has joined as General Manager – North America. With more than 20 years’ experience in biostimulants, seed technology […]

Vancouver, Canada-based Renaissance BioScience Corp. has retained the services of S. Brad Griffith to assist Renaissance in commercializing its RNA production and oral delivery platform technology […]

Pivot Bio and Monsanto Company, a member of the Bayer Group, announced a collaboration entered into earlier this year to develop Bradyrhizobium strains with enhanced nitrogen production […]

Exosect Ltd announced a licensing deal with Monsanto to use its Entostat technology for the delivery of select agricultural biologicals as seed treatments. This deal […]

Monsanto BioAg products will now be offered under the newly formed Acceleron BioAg brand, as part of a larger seed treatment portfolio rebranding effort with […]

Monsanto BioAg products will now be offered under the newly formed Acceleron BioAg brand, as part of a larger seed treatment portfolio rebranding effort with […]

Canadian pulse crop are benefiting from the addition of biologicals to seed inoculants. Both BASF and Monsanto BioAg have incorporated biologicals into seed inoculants used in […]

The BioAg Alliance, Monsanto’s and Novozymes’ collaboration announced results from its 2016 field trial program and shared an updated research pipeline. Acceleron B-300 SAT is […]

Bayer and Monsanto announced that they signed a definitive merger agreement under which Bayer will acquire Monsanto for USD 128 per share in an all-cash […]

The BioAg Alliance, a collaboration between Novozymes and Monsanto to improve crop harvests through naturally-occurring microbes, announced results from its 2015 field trial program. Those […]

Monsanto and Novozymes announced a new 2025 acreage target that will guide the companies’ microbials business for the next decade. The two partners envision that […]